Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 605-610

  Sánchez, Jose E ^a   Ortega, Teresa ^a   Rodríguez, Carmen ^a   Díaz Molina, Beatriz ^a   Martín, Maria ^a   Garcia Cueto, Carmen ^a   Vidau, Pedro ^a   Gago, Emilio ^a   Ortega, Francisco ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Congestive heart failure; Costs; Peritoneal dialysis; Quality of life; Ultrafiltration

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST UTILITY ANALYSIS; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; ULTRAFILTRATION;

COSTS AND COST ANALYSIS; FEMALE; HEART FAILURE; HEMODIAFILTRATION; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES;

EID: 75649117398     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp484     Document Type: Article

References (18)

1. Cortina A, Reguero J, Segovia E et al. Prevalence of heart failure in Asturias (a region in the north of Spain). Am J Cardiol 2001; 87: 1417-1419
2. Mart́inez-Sellés M, Garćia Robles JA, Prieta L et al. Annual rates of admission and seasonal variations in hospitalizations for heart failure. Eur J Heart Fail 2002; 4: 779-786
3. Rodriguez Artalejo F, Guallar Castillón P, Banegas Banegas JR et al. Trends in hospitalization and mortality for congestive heart failure in Spain, 1980-1993. Eur Heart J 1997; 18: 1771-1779
4. Cadnapaphornchai MA, Gurevich AK, Weinberger HD et al. Patho-physiology of sodium and water retention in heart failure. Cardiology 2001; 96: 122-131
5. Gil P, Justo S, Castilla MA et al. Cardio-renal insufficiency: the search for management strategies. Curr Opin Nephrol Hypertens 2005; 14: 442-447
6. Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol 2005; 95: 8B-13B
7. Silverberg D, Wexler D, Blum M et al. The cardio-renal-anaemia syndrome: does it exist? Nephrol Dial Transplant 2003; 18(Suppl 8): viii7-viii12
8. Alpert MA, Huting J, Twardowski ZJ et al. Continuous ambulatory peritoneal dialysis and the heart. Perit Dial Int 1995; 15: 6-11
9. Takane H, Nakamoto H, Arima H et al. Continuous ambulatory peritoneal dialysis is effective for patients with severe congestive heart failure. Adv Perit Dial 2006; 22: 141-146
10. Hébert MJ, Falardeau M, Pichette V et al. Continuous ambulatory peritoneal dialysis for patients with severe left ventricular systolic dysfunction and end-stage renal disease. Am J Kidney Dis 1995; 25: 761-768
11. Cappola TP, Felker GM, Kao WH et al. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation 2002; 105: 1663-1668
12. Jessup M, Brozena S. Heart failure. N Engl JMed 2003; 348: 2007-2018
13. Bad́ia X, Roset M, Montserrat S et al. La version espanola del Eu-roQol: descripcion y aplicaciones. Med Cĺin (Barc) 1999; 112(Suppl 1): 79-86
14. Drummond MF, O'Brien B, Stoddart GL et al. Methods for the Economic Evaluation of Health Care Programmes. 2nd edn. Oxford: Oxford Medical Publications, 1997
15. Hoch JS, Briggs AH, Willan AR. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ 2002; 11: 415-430
16. Diwan A, Tran T, Misra A et al. Inflammatory mediators and the failing heart: a translational approach. Curr Mol Med 2003; 3: 161-182
17. Zoccali C, Mallamaci F, Benedetto FA et al. Cardiac natriuretic pep-tides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-1515
18. Rodŕiguez-Carmona A, Castro A, Pérez Fontán M et al. Economic study of dialysis using the cost-procedure clinical protocol-adjusted method. Nefrologia 2007; 27: 359-369